EcoDrugPlus

Ensembl ID : ENSODEG00000000640
Gene Symbol: -
Cross references: -
109 Possible Orthologues:

Ensembl ID : ENSODEG00000002537
Gene Symbol: -
Cross references: -
109 Possible Orthologues:

Ensembl ID : ENSODEG00000020390
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSODEG00000010202
Gene Symbol: -
Cross references: -
93 Possible Orthologues:

Ensembl ID : ENSODEG00000003845
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSODEG00000006851
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSODEG00000009898
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSODEG00000013320
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSODEG00000013958
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSODEG00000000728
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSODEG00000004775
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSODEG00000009967
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).